Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

This publication has 21 references indexed in Scilit:

• Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study
  The Lancet, 2007
• Rotavirus vaccines: current prospects and future challenges
  The Lancet, 2006
• Vacinas contra rotavírus e papilomavírus humano (HPV)
  Jornal de Pediatria, 2006
• Rotavirus and Severe Childhood Diarrhea
  Emerging Infectious Diseases, 2006
• Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis
  New England Journal of Medicine, 2006
• Clinical and Epidemiological Aspects of Rotavirus Infection
  Pediatric Annals, 2006
• Rotarix: Development of a Live Attenuated Monovalent Human Rotavirus Vaccine
  Pediatric Annals, 2006
• Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine
  Reviews in Medical Virology, 2004
• Rotavirus vaccines and vaccination in Latin America
  Revista Panamericana de Salud Pública, 2000
• Rotavirus Infection in Infants as Protection against Subsequent Infections
  New England Journal of Medicine, 1996